We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
Respiratory complications after coronary artery bypass surgery with unilateral or bilateral internal mammary artery grafting.
Chest 1998 May
BACKGROUND AND STUDY OBJECTIVE: Use of bilateral internal mammary artery (IMA) grafts during coronary artery revascularization procedures carries the potential for increased incidence of postoperative respiratory complications compared with use of unilateral IMA grafts. The purpose of this study was to compare the incidence of respiratory complications such as hypoxemia, atelectasis, pleural effusion, and diaphragmatic dysfunction in patients who received one or both IMAs as conduit grafts.
DESIGN: Prospective, comparative study.
SETTING: Surgical ICU at a tertiary teaching hospital.
PATIENTS: Seventy-five patients with bilateral and 75 patients with unilateral IMA grafts.
MEASUREMENTS: Serial postoperative PaO2/fraction of inspired oxygen measurements, radiographic scores of atelectasis and pleural effusion, duration of mechanical ventilation, length of ICU and hospital stay, and incidence of pneumothorax, pneumonia, and wound infection.
RESULTS: There was a higher incidence (51% vs 25%; p=0.002) and severity (0.48+/-0.09 vs 0.15+/-0.05 on the first postoperative day, 0.39+/-0.07 vs 0.27+/-0.07 on the fourth postoperative day, mean+/-SEM; p=0.004) of postoperative right lower lobe atelectasis in the group who received bilateral IMA grafts than in those who received left IMA grafts. This finding probably reflects the effects of additional surgical intervention on the right side of the chest. Incidence and severity of pleural effusion, gas exchange impairment, duration of mechanical ventilation, ICU and hospital stay, and incidence of pneumothorax, pneumonia, and wound infection were not influenced by use of bilateral IMA grafts (p>0.05).
CONCLUSION: We conclude that use of bilateral IMA grafts during coronary artery revascularization does not increase the incidence of postoperative respiratory complications compared with unilateral IMA grafting.
DESIGN: Prospective, comparative study.
SETTING: Surgical ICU at a tertiary teaching hospital.
PATIENTS: Seventy-five patients with bilateral and 75 patients with unilateral IMA grafts.
MEASUREMENTS: Serial postoperative PaO2/fraction of inspired oxygen measurements, radiographic scores of atelectasis and pleural effusion, duration of mechanical ventilation, length of ICU and hospital stay, and incidence of pneumothorax, pneumonia, and wound infection.
RESULTS: There was a higher incidence (51% vs 25%; p=0.002) and severity (0.48+/-0.09 vs 0.15+/-0.05 on the first postoperative day, 0.39+/-0.07 vs 0.27+/-0.07 on the fourth postoperative day, mean+/-SEM; p=0.004) of postoperative right lower lobe atelectasis in the group who received bilateral IMA grafts than in those who received left IMA grafts. This finding probably reflects the effects of additional surgical intervention on the right side of the chest. Incidence and severity of pleural effusion, gas exchange impairment, duration of mechanical ventilation, ICU and hospital stay, and incidence of pneumothorax, pneumonia, and wound infection were not influenced by use of bilateral IMA grafts (p>0.05).
CONCLUSION: We conclude that use of bilateral IMA grafts during coronary artery revascularization does not increase the incidence of postoperative respiratory complications compared with unilateral IMA grafting.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app